31 January 2017

By Dr Wendy Winnall - PCFA Research Team

Genomics research helps predict which prostate cancers are the most dangerous

Personalised medicine is an approach that uses patient-specific information to guide the best treatment pathway. For personalised medicine to become a reality for prostate cancer we need to know what markers to test for, and how to use this information to optimise treatment. A lot of research is required to establish this knowledge base. Two new studies from January 2017 have laid important groundwork in this area. These studies will hopefully lead to a test that can identify which localised tumours will turn into more dangerous cancers, identifying patients that need stronger initial treatment.

To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.


Join Online Community Button